1. Apoptosis and inhibition of gap-junctional intercellular communication induced by LA-12, a novel hydrophobic platinum(IV) complex.
- Author
-
Procházka L, Turánek J, Tesarík R, Knotigová P, Polásková P, Andrysík Z, Kozubík A, Zák F, Sova P, Neuzil J, and Machala M
- Subjects
- Amantadine pharmacology, Animals, Cell Line, Cell Line, Tumor, Cisplatin pharmacology, Connexin 43 metabolism, Dose-Response Relationship, Drug, Epithelial Cells metabolism, Hydrophobic and Hydrophilic Interactions, Phosphorylation, Rats, Amantadine analogs & derivatives, Antineoplastic Agents pharmacology, Apoptosis, Gap Junctions drug effects, Organoplatinum Compounds pharmacology, Platinum Compounds chemistry
- Abstract
A new hydrophobic platinum(IV) complex, LA-12, a very efficient anticancer drug lacking cross-resistance with cisplatin (CDDP), is now being tested in clinical trials. Here we investigated the apoptogenic activity of LA-12 and its effect on gap-junctional intercellular communication (GJIC) in the rat liver epithelial cell line WB-F344. LA-12 induced apoptosis much more efficiently than did CDDP due to a combination of rapid penetration into the cell and attack on DNA, leading to fast activation of p53 and caspase-3. Exposure of WB-F344 cells to LA-12 led to rapid induction of the time- and dose-dependent decrease in GJIC. On the molecular level, loss of GJIC induced by LA-12 was mediated by activation of extracellular signal-regulated kinase (ERK)-1 and ERK-2, as demonstrated by the use of inhibitors of ERK activation. Inhibition of GJIC was linked to rapid hyperphosphorylation of connexin-43 and disappearance of connexon clusters from membranes, which was not observed in the case of CDDP.
- Published
- 2007
- Full Text
- View/download PDF